is metformin a glp 1 Disproportionality analysis of GLP-1 receptor agonists combined with based on the FAERS database Similar cellular effects of metformin,

Patients with a history of pancreatitis or medullary thyroid cancer, or with a personal or family history of multiple endocrine neoplasia 2 (MEN2), are advised not to take these drugs

However, regulatory guidance states that when the ratio of the area under the concentration-time curve (AUC) of the victim drug with and without the perpetrator drug falls outside the range of 0.81.25, there is a potential risk of a clinically significant impact, necessitating further investigation

[DOI] [PubMed] [Google Scholar] 232.Iepsen E.W., Torekov S.S., Holst J.J

Saudi J Biol Sci

Besides GLP-1 secretion, mice treated with DBZ show increased insulin secretion and improved glucose tolerance

This narrative review summarizes current knowledge on the benefit/risk profile of GLP-1 RAs, highlighting their impact for dermatologists and plastic surgeons in relevant contexts